This shorter relaxation time in the in vitro assay strongly suggests that MUC16-targeted huAR9.6–Gd–DTPA could aid in detecting MUC16-bearing pancreatic cancer cells and lesions. This evidence concerns the gene MUC16 and pancreatic neoplasm.